本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioNTech SE

105.14
+0.06000.06%
盘后105.140.00000.00%17:22 EDT
成交量:48.79万
成交额:5,118.57万
市值:252.34亿
市盈率:-62.38
高:105.58
开:103.10
低:103.10
收:105.08
52周最高:129.27
52周最低:81.20
股本:2.40亿
流通股本:9,380.89万
量比:0.67
换手率:0.52%
股息:- -
股息率:- -
每股收益(TTM):-1.6856
每股收益(LYR):-2.8652
净资产收益率:-1.84%
总资产收益率:-2.14%
市净率:1.17
市盈率(LYR):-36.70

数据加载中...

2025/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/08/08

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/06/17

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/06/13

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/06/12

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/06/12

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/06/12

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/06/12

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/06/04

关联方拟减持公告

Form 144 | BioNTech SE董事 Helmut Jeggle拟减持150000股,总价约1697万美元
2025/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/10

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities